Skip to main content
. 2023 Feb 13;14:1110775. doi: 10.3389/fimmu.2023.1110775

Table 2.

Comparison of biomarkers between the MDD group and HC group.

Project MDD (N=113)
Mean ± SD/Median (IQR 25–75)
HC (N=41)
Mean ± SD/Median (IQR 25–75)
p-value
proBDNF (ng/mL) 2.936 ± 1.556 2.602 ± 1.330 0.368
HMGB1 (pg/mL) 117.995 ± 28.077 130.194 ± 26.379 0.018
TNF-α (pg/mL) 13.347 ± 1.241 12.901 ± 0.227 0
BDNF (pg/mL) 3.900 (2.491, 6.223) 3.19 (0.2.313, 4.784) 0.209
hs-CRP (mg/L) 2.347 (2.003, 2.656) 2.300 (1.500, 2.675) 0.463
IL-4 (pg/mL) 6.640 (4.494, 8.042) 6.640 (4.081, 9.097) 0.974
IL-6 (pg/mL) 2.106 (0.426, 2.727) 0.421 (0.391, 0.572) 0
IL-10 (pg/mL) 3.130 (2.699, 3.594) 3.189 (2.752, 3.956) 0.280
IL-18 (pg/mL) 3.465 (2.354, 5.690) 4.104 (2.196, 5.714) 0.792
IL-23 (pg/mL) 2.776 (2.286, 3.415) 2.570 (2.071, 3.195) 0.944

MDD, major depressive disorder; HC, healthy control; proBDNF, brain-derived neurotrophic factor precursor; HMGB1, high mobility group protein 1; TNF-α, tumor necrosis factor-α; BDNF, brain-derived neurotrophic factor; hs-CRP, hypersensitive C-reactive protein; IL, interleukin.